Sara KamaliZonouzi

Sara KamaliZonouzi

Auto-generated profile, based on publicly available information

Sara KamaliZonouzi

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Ophthalmic Research
Verified
Journal Article
Open access
NHNasim Hosseinzadeh
Nasim Hosseinzadeh
MMMehrdad Mahalleh
Mehrdad Mahalleh
SKSara KamaliZonouzi
Sara KamaliZonouzi
SASogol Alikarami
Sogol Alikarami
MGMahdi Gouravani
Mahdi Gouravani
JAJ. Fernando Arévalo
J. Fernando Arévalo
Introduction: The purpose of this systematic review and meta-analysis was to compare optical coherence tomography (OCT) retinal measurements between patients with autism spectrum disorder (ASD) and the neurotypical controls, exploring the potential of OCT as a noninvasive biomarker for ASD-related neurodevelopmental alterations. Methods: PubMed, Embase, and Scopus databases were explored to determine eligible articles reporting OCT measurements of the retina and choroid in patients with ASD compared to healthy controls. Statistical analysis of OCT metrics was performed if reported in at least three discrete studies. In the process, fixed- and random-effects models were utilized, depending on the heterogeneity level between studies. Subgroup analysis based on the age group of cases, the method of eye selection, age and sex matching of cases and controls, and the OCT device used was also conducted. Results: Ten studies with 373 ASD cases (with a total of 640 eyes) and 443 controls (with a total of 760 eyes) were included in this study. No significant alteration was observed in the average total macular layer, macular inner nuclear layer (INL), macular inner plexiform layer (IPL), macular ganglion cell layer (GCL), and macular retinal nerve fiber layer (RNFL) thickness. There was also no significant difference in the peripapillary retinal nerve fiber layer (pRNFL) thickness of the eyes of cases with ASD compared to healthy controls, except for the inferonasal portion of the pRNFL, which was significantly thicker in ASD subjects when compared to controls (p = 0.02). Conclusion: The findings of the present meta-analysis indicate a localized thickening of the inferonasal pRNFL with no alteration of other portions of pRNFL and macular layers (IPL, INL, GCL, RNFL). Although OCT may reflect subtle neurodevelopmental differences in ASD, current evidence is limited by small sample sizes, methodological heterogeneity, and potential confounders.

16 February 2026 in Case Reports in Ophthalmology
Verified
Journal Article
Open access
SKSara KamaliZonouzi
Sara KamaliZonouzi
JMJonathan Micieli
Jonathan Micieli
Background: Hereditary optic neuropathies are primarily disorders of mitochondrial dysfunction leading to the metabolic failure of the highly energy-dependant retinal ganglion cells. Beyond the canonical variants found in OPA1 or the mitochondrial genome, a growing subset of patients exhibit progressive optic atrophy of unknown origin. Identifying these variants is critical, as they might lead to a diagnostic delay. We report two cases with a previously unreported MT-RNR1 variants, potentially contributing to a hereditary optic neuropathy. Case presentation: A 55-year-old woman with painless progressive optic neuropathy presented with bilateral central scotomas and temporal optic disc pallor. Nutritional, inflammatory, and demyelinating causes were excluded. Genetic testing revealed MT-RNR1:m.1019A>G variant, potentially contributing to a hereditary optic neuropathy. A 59-year-old woman with similar bilateral temporal pallor and symmetric retinal nerve fiber layer thinning was found to harbor MT-RNR1:m.1183T>C variant. Conclusion: MT-RNR1 gene variant was the possible cause of vision loss in these patients with mild vision loss and a clinical picture consistent with a hereditary optic neuropathy. Herein, we describe two novel variants and associated clinical features. This case report introduces a previously unrecognized genetic variant, potentially contributing to a hereditary optic neuropathy.

23 March 2026 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
SKSara KamaliZonouzi
Sara KamaliZonouzi
MAMobina Amanollahi
Mobina Amanollahi
MFMelina Farshbafnadi
Melina Farshbafnadi
MDMahsa Dolatshahi
Mahsa Dolatshahi
CRCyrus A. Raji
Cyrus A. Raji
Background: Retinal imaging is proposed as a biomarker for Alzheimer's disease, but evidence linking retinal changes to cerebral amyloid remains inconsistent, particularly in preclinical populations. Objective: This article evaluates whether retinal structural and microvascular changes measured by optical coherence tomography (OCT) and OCT-angiography (OCT-A) are associated with cerebral amyloid-β (Aβ) burden assessed by positron emission tomography (PET). Methods: PubMed, Embase, Scopus, and Web of Science were searched on November 10, 2025. Two reviewers independently did screening, extraction, and quality assessment. Extracted outcomes included macular and peripapillary retinal nerve fiber layer and ganglion cell–inner plexiform layer thickness, vessel density, foveal avascular zone size, and PET tracers. Results: Twenty-two studies including 1616 participants met inclusion criteria. Fifteen assessed OCT, five OCT-A, and two both. Among cognitively normal individuals, seven studies compared retinal nerve fiber layer thickness by Aβ status, with only one reporting a significant difference. Overall, OCT metrics showed no consistent differences by Aβ status. OCT-A results were similarly inconsistent, with one study linking larger foveal avascular zone to Aβ positivity. Substantial heterogeneity in imaging devices, segmentation methods, and PET quantification was observed, and few studies adjusted for these factors. Conclusions: Current evidence does not demonstrate a consistent relationship between retinal OCT or OCT-A metrics and cerebral Aβ burden measured by PET. Methodological heterogeneity, small sample sizes, and limited statistical rigor contribute to inconclusive results. Standardized imaging protocols and longitudinal studies are required to determine whether retinal imaging can serve as a reliable non-invasive biomarker for early Alzheimer's disease.

19 June 2026 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
SZSara Kamali Zonouzi
Sara Kamali Zonouzi
SJSamira Jafari
Samira Jafari
EMEdward Margolin
Edward Margolin
JMJonathan A. Micieli
Jonathan A. Micieli
Optic neuritis is often managed by neuro-ophthalmologists. Neuro-imaging plays an important role in diagnosis. Radiologists can influence care by communicating pertinent findings and recommending next steps. Increasingly, patients have direct access to their reports, which may affect their understanding, anxiety, and interactions with clinicians. This study aimed to characterize the frequency and nature of radiologists' recommendations in magnetic resonance imaging (MRI) reports for optic neuritis. A retrospective chart review. Patients referred to a tertiary neuro-ophthalmology clinic between November 2007 and May 2025 with new-onset optic neuritis and no prior demyelinating disease METHODS: Data on imaging protocols, diagnostic terminology, differential diagnoses, recommendations, and incidental findings were obtained from electronic medical records. We included 219 MRI reports (73.1% female; mean age: 37.4 ± 13.1 years). MRI of the brain and orbit was the most common protocol (73.5%). Signs of demyelination or possible demyelination were noted in 109 cases (49.8%). Overall, recommendations were provided in 16.0% (35/219) to patients, with 20.2% (22/109) of those showing demyelination compared with 2.7% (3/110) without demyelination. The top 3 recommendations were an MRI of the spine (17/22; 77.3%), follow-up imaging (2/22; 9.1%), and follow-up appointment with patient and MRI of orbit (1/22; 4.5% each). Among participating radiologists, recommendations were given to patients in a minority of optic neuritis cases, with MRI of the spine being the most common recommendation. There was a higher likelihood of a recommendation if there were brain changes (20%) compared with no brain changes (3%). These findings highlight variability in reporting practices and support the adoption of standardized language for describing optic nerve abnormalities and appropriate follow-up, reducing unnecessary testing and potential patient anxiety.

1 January 2025 in Case Reports in Ophthalmology
Verified
Journal Article
Open access
BEBahram Eshraghi
Bahram Eshraghi
SKSara KamaliZonouzi
Sara KamaliZonouzi
MPMohsen Pourazizi
Mohsen Pourazizi
SGSarah Ghorbani
Sarah Ghorbani
Introduction: Thyroid eye disease (TED) is a known complication of Graves’ disease, but severe presentations with bilateral corneal melting ulcers are rare. Simultaneous substance use disorder might make the disease management more challenging. Case Presentation: Herein, we present a 29-year-old man with a history of Graves’ disease who, despite prior hospitalization for milder symptoms, experienced a deterioration of his condition, leading to bilateral corneal melting ulcers. He was treated with fortified ophthalmic antibiotic drops, and methimazole dosage was increased. Intravenous methylprednisolone and mycophenolate mofetil were also started. Urgent orbital decompression on medial and inferior walls, canthotomy/cantholysis, and medial and lateral tarsorrhaphy were performed, followed by conjunctival flap placement and bilateral total blepharorrhaphy. Despite comprehensive treatment, the patient exhibited a poor therapeutic response and ultimately retained only light perception in both eyes. Conclusion: The patient’s complex medical history including homelessness and substance abuse complicated both diagnosis and management. This case highlights the challenges in treating severe TED and underscores the importance of timely intervention and patient compliance.

18 December 2025 in Case Reports in Ophthalmology
Verified
Journal Article
Open access
SKSara KamaliZonouzi
Sara KamaliZonouzi
JMJonathan Micieli
Jonathan Micieli
Introduction: Leber hereditary optic neuropathy (LHON) is a hereditary optic neuropathy mainly caused by mutations at 1,178, 14,484, and 3,460 in mitochondrial DNA. Patients with LHON have a higher risk of developing multiple sclerosis (MS), a coexistence also known as Harding’s syndrome. A growing body of evidence shows that other mitochondrial and non-mitochondrial mutations can lead to LHON and Harding’s syndrome. Herein, we report a novel mutation in MT-RNR2 resulting in LHON. Case Presentation: A 35-year-old woman with bilateral painless optic neuropathy presented to neuro-ophthalmology clinic. Her blood work-up did not reveal any nutritional deficiencies, and she did not respond to steroid therapy. Genetic test revealed a m.1737A>G mutation in MT-RNR2 gene with 99.9% penetrance; therefore, she was diagnosed with LHON. Conclusion: MT-RNR2 gene mutation was the possible cause for LHON in this patient. Herein, we describe a novel mutation and associated clinical features. This case report also underscores the importance of considering LHON as a differential diagnosis for optic neuritis, even in a patient with an established MS.